# A Review of Ionizing Radiation-Induced Senescence of Bone Marrow Mesenchymal Stem/Stromal Cells: Mechanisms and Therapeutic Strategies

**Authors:** Xiaoliang Li, Maoshan Chen, Yangyang Zhang, Jiuxuan Li, Lixin Xiang, Yanni Xiao, Yang Xiang, Li Chen, Qian Ran, Zhongjun Li

PMC · DOI: 10.3390/cimb48020196 · 2026-02-10

## TL;DR

This review explores how radiation causes bone marrow stem cells to age prematurely, affecting blood cell production and suggesting ways to treat this issue.

## Contribution

The paper systematically reviews mechanisms and therapeutic strategies for radiation-induced senescence in BM-MSCs.

## Key findings

- Ionizing radiation induces senescence in BM-MSCs, disrupting the bone marrow niche and contributing to radiation sickness.
- The senescence of BM-MSCs is dependent on the type and dose of radiation exposure.
- Senotherapeutic strategies targeting BM-MSCs senescence are outlined for potential interventions.

## Abstract

Bone marrow mesenchymal stem/stromal cells (BM-MSCs) are important components of bone marrow, possessing multipotent differentiation potential and the ability to support hematopoiesis. Exposure to ionizing radiation (IR) induces cellular damage in BM-MSCs, such as DNA lesions and mitochondrial dysfunction. Despite their relative radioresistance, most surviving BM-MSCs enter senescence post-irradiation. This senescent state disrupts the bone marrow niche, impairs stem cell proliferation and differentiation, and contributes to acute radiation syndrome (ARS) and myelosuppression. To clarify the impact of IR on BM-MSCs, this review systematically summarizes the general mechanisms of radiation-induced cellular senescence, examines the effects of different radiation types (e.g., gamma rays, X-rays, and heavy-ion radiation) and doses on BM-MSCs senescence, and outlines senotherapeutic strategies targeting BM-MSCs senescence. The analysis indicates that the senescence of BM-MSCs caused by IR is type- and dose-dependent. The review identifies key factors in IR-induced BM-MSCs senescence to guide targeted interventions, highlighting the need for future studies to elucidate the underlying mechanisms of IR-induced BM-MSCs senescence.

## Linked entities

- **Diseases:** acute radiation syndrome (MONDO:0033938)

## Full-text entities

- **Genes:** Cat (catalase) [NCBI Gene 12359] {aka 2210418N07, Cas-1, Cas1, Cs-1}, Trp53bp1 (transformation related protein 53 binding protein 1) [NCBI Gene 27223] {aka 53BP1, Tp53bp1, m53BP1, p53BP1}, ACSM3 (acyl-CoA synthetase medium chain family member 3) [NCBI Gene 6296] {aka SA, SAH}, ATM (ATM serine/threonine kinase) [NCBI Gene 472] {aka AT1, ATA, ATC, ATD, ATDC, ATE}, Atr (ataxia telangiectasia and Rad3 related) [NCBI Gene 245000], Mdm2 (MDM2 proto-oncogene) [NCBI Gene 17246] {aka 1700007J15Rik, Mdm-2}, Bax (BCL2-associated X protein) [NCBI Gene 12028], Atm (ataxia telangiectasia mutated) [NCBI Gene 11920] {aka C030026E19Rik}, Stat3 (signal transducer and activator of transcription 3) [NCBI Gene 25125], Tbk1 (TANK-binding kinase 1) [NCBI Gene 56480] {aka 1200008B05Rik}, Bcl2l11 (BCL2 like 11) [NCBI Gene 12125] {aka 1500006F24Rik, Bim, Bod, bcl2-L-11}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56717] {aka 2610315D21Rik, FRAP, FRAP2, Frap1, RAFT1, RAPT1}, CCL22 (C-C motif chemokine ligand 22) [NCBI Gene 6367] {aka A-152E5.1, ABCD-1, DC/B-CK, MDC, SCYA22, STCP-1}, Sting1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 72512] {aka 2610307O08Rik, ERIS, MPYS, Mita, STING, STING-beta}, Hmox1 (heme oxygenase 1) [NCBI Gene 15368] {aka D8Wsu38e, HO-1, HO1, Hemox, Hmox, Hsp32}, CCNB1 (cyclin B1) [NCBI Gene 891] {aka CCNB}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, Chek2 (checkpoint kinase 2) [NCBI Gene 50883] {aka CHK2, Cds1, HUCDS1, Rad53}, IL12B (interleukin 12B) [NCBI Gene 3593] {aka CLMF, CLMF2, IL-12B, IMD28, IMD29, NKSF}, Mmp12 (matrix metallopeptidase 12) [NCBI Gene 117033] {aka Mme}, Cdkn2a (cyclin dependent kinase inhibitor 2A) [NCBI Gene 12578] {aka ARF-INK4a, Arf, INK4a-ARF, Ink4a/Arf, MTS1, Pctr1}, E2f1 (E2F transcription factor 1) [NCBI Gene 13555] {aka E2F-1, Tg(Wnt1-cre)2Sor, mKIAA4009}, Cdk4 (cyclin dependent kinase 4) [NCBI Gene 12567] {aka Crk3}, MAP2K7 (mitogen-activated protein kinase kinase 7) [NCBI Gene 5609] {aka JNKK2, MAPKK7, MEK, MEK 7, MKK7, PRKMK7}, Acsm3 (acyl-CoA synthetase medium-chain family member 3) [NCBI Gene 20216] {aka Sa, Sah}, CHEK2 (checkpoint kinase 2) [NCBI Gene 11200] {aka CDS1, CHK2, HuCds1, LFS2, PP1425, RAD53}, Il6 (interleukin 6) [NCBI Gene 24498] {aka ILg6, Ifnb2}, Tfam (transcription factor A, mitochondrial) [NCBI Gene 21780] {aka Hmgts, mtTFA, tsHMG}, Mmp9 (matrix metallopeptidase 9) [NCBI Gene 17395] {aka B/MMP9, Clg4b, Gel B, MMP-9, pro-MMP-9}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, Pou5f1 (POU domain, class 5, transcription factor 1) [NCBI Gene 18999] {aka NF-A3, Oct-3, Oct-3/4, Oct-4, Oct3, Oct3/4}, Creb3l1 (cAMP responsive element binding protein 3-like 1) [NCBI Gene 26427] {aka Oasis}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Rb1 (RB transcriptional corepressor 1) [NCBI Gene 19645] {aka Rb, Rb-1, p110-RB1, pRb, pp105}, Sox2 (SRY (sex determining region Y)-box 2) [NCBI Gene 20674] {aka Sox-2, lcc, ysb}, CHEK1 (checkpoint kinase 1) [NCBI Gene 1111] {aka CHK1, OZEMA21}, TXN (thioredoxin) [NCBI Gene 7295] {aka TRDX, TRX, TRX1, TXN1, Trx80}, CCNE2 (cyclin E2) [NCBI Gene 9134] {aka CYCE2}, Kitl (kit ligand) [NCBI Gene 17311] {aka Clo, Con, Gb, Kitlg, Mgf, SCF}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, GADD45GIP1 (GADD45G interacting protein 1) [NCBI Gene 90480] {aka CKBBP2, CKbetaBP2, CRIF1, MRP-L59, PLINP, PLINP-1}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, Ido1 (indoleamine 2,3-dioxygenase 1) [NCBI Gene 15930] {aka Ido, Indo}, Ccl22 (C-C motif chemokine ligand 22) [NCBI Gene 20299] {aka ABCD-1, DCBCK, MDC, Scya22}, Prdx6-ps2 (peroxiredoxin 6 pseudogene 2) [NCBI Gene 384001] {aka Aop2-rs2, GPx*, Prdx6-rs2}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, Gadd45gip1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) [NCBI Gene 102060] {aka 2310040G17Rik, Crif1, MRP-L59, Plinp1}, Cxcl12 (C-X-C motif chemokine ligand 12) [NCBI Gene 20315] {aka Pbsf, Scyb12, Sdf1, Tlsf, Tpar1}, Cxcl1 (C-X-C motif chemokine ligand 1) [NCBI Gene 14825] {aka Fsp, Gro1, KC, Mgsa, N51, Scyb1}, Trp53 (transformation related protein 53) [NCBI Gene 22059] {aka Tp53, bbl, bfy, bhy, p44, p53}, Tnfsf11 (tumor necrosis factor (ligand) superfamily, member 11) [NCBI Gene 21943] {aka Ly109l, ODF, OPGL, RANKL, Trance}, Bcl2 (B cell leukemia/lymphoma 2) [NCBI Gene 12043] {aka Bcl-2, C430015F12Rik, D630044D05Rik, D830018M01Rik}, H1-0 (H1.0 linker histone) [NCBI Gene 3005] {aka H1.0, H10, H1F0, H1FV}, PRKDC (protein kinase, DNA-activated, catalytic subunit) [NCBI Gene 5591] {aka DNA-PKC, DNA-PKcs, DNAPK, DNAPKc, DNPK1, HYRC}, Mmp9 (matrix metallopeptidase 9) [NCBI Gene 81687], Bak1 (BCL2-antagonist/killer 1) [NCBI Gene 12018] {aka Bak, N-BAK1, N-Bak}, CREB1 (cAMP responsive element binding protein 1) [NCBI Gene 1385] {aka CREB, CREB-1}, Stat3 (signal transducer and activator of transcription 3) [NCBI Gene 20848] {aka 1110034C02Rik, Aprf}, Cgas (cyclic GMP-AMP synthase) [NCBI Gene 214763] {aka E330016A19Rik, Mb21d1}
- **Diseases:** injury to (MESH:D014947), osteogenic dysfunction (MESH:D012516), chronic inflammation (MESH:D007249), CLL (MESH:D015451), Mitochondrial dysfunction (MESH:D028361), MM (MESH:D009101), tumor (MESH:D009369), NK (MESH:D054066), graft-versus-host disease (MESH:D006086), carcinogenesis (MESH:D063646), AML (MESH:D015470), hematological malignancies (MESH:D019337), natural killer (MESH:D000077428), leukemia (MESH:D007938), ataxia-telangiectasia (MESH:D001260), bone damage (MESH:D001847), cytotoxicity (MESH:D064420), tumor suppressor protein (OMIM:601308), ARS (MESH:D054508), calcium (MESH:D002128), TBI (MESH:D012793), necrosis (MESH:D009336), intestinal injury (MESH:D007410)
- **Chemicals:** sugar (MESH:D000073893), oxygen (MESH:D010100), Ginsenoside Rg1 (MESH:C035054), Quercetin (MESH:D011794), carbon (MESH:D002244), Rapamycin (MESH:D020123), Cesium-137 (MESH:C000614989), water (MESH:D014867), Ibrutinib (MESH:C551803), Metformin (MESH:D008687), Americium-241 (MESH:C000615192), ferulic acid (MESH:C004999), iron-56 (MESH:D007501), PGE2 (MESH:D015232), Rg1 (-), H2O2 (MESH:D006861), 4He (MESH:D006371), Fisetin (MESH:C017875), MMS350 (MESH:C586473), Dasatinib (MESH:D000069439), reactive nitrogen species (MESH:D026361), reversine (MESH:C484369), lipid (MESH:D008055), OH (MESH:C031356), NAD (MESH:D009243), Cobalt-60 (MESH:C000615395), RNS (MESH:D011886), Spermidine (MESH:D013095), ROS (MESH:D017382)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939758/full.md

---
Source: https://tomesphere.com/paper/PMC12939758